BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36497274)

  • 1. Changes in Treatment Patterns and Costs for Lung Cancer Have Not Resulted in Relevant Improvements in Survival: A Population-Based Observational Study in Catalonia.
    Guarga L; Paco N; Vela E; Clèries M; Corral J; Delgadillo J; Pontes C; Borràs JM
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management, Survival, and Costs of Pancreatic Cancer: Population-Based Observational Study in Catalonia.
    Guarga L; Paco N; Manchon-Walsh P; Vela E; Delgadillo J; Pontes C; Borràs JM
    Int J Environ Res Public Health; 2023 Apr; 20(9):. PubMed ID: 37174192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study.
    Carreras MJ; Tomás-Guillén E; Farriols A; Renedo-Miró B; Valdivia C; Vidal J; Saura C; Carles J; Felip E; Gorgas MQ; Tabernero J; Monterde J
    Curr Oncol; 2023 Aug; 30(9):7984-8004. PubMed ID: 37754495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
    Park HY; Hwang J; Kim DH; Jeon SM; Choi SH; Kwon JW
    BMC Cancer; 2020 Sep; 20(1):846. PubMed ID: 32883237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare Resource Utilization and Associated Costs among Patients with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain: A Single-Center, Real-World, Exploratory Study.
    Ginés Rubió J; Delgado O; Callejo A; Domínguez M; Torres C
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study.
    Garrido-Alejos G; Saborit-Canals G; Guarga L; de Pando T; Umbria M; Oriol A; Feliu A; Pontes C; Vallano A
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cost study of first- line treatment of metastatic colorectal carcinoma with bevacizumab- containing regimen in the Czech Republic].
    Hradecká I; Ríhová B; Horová R; Demlová R
    Klin Onkol; 2014; 27(4):255-60. PubMed ID: 25115714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer follow-up costs in Germany from 2000 to 2015.
    Michaeli T; Michaeli D
    J Cancer Surviv; 2022 Feb; 16(1):86-94. PubMed ID: 33646503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Arunachalam A; Li H; Bittoni MA; Camacho R; Cao X; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e783-e799. PubMed ID: 29983370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Innovations in Radiotherapy and Systemic Treatments With Clinical Outcomes in Patients With Melanoma Brain Metastasis From 2007 to 2016.
    Brastianos HC; Nguyen P; Sahgal A; Eisenhauer EA; Baetz T; Hanna TP
    JAMA Netw Open; 2020 Jul; 3(7):e208204. PubMed ID: 32663310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MODEL-BASED COST-EFFECTIVENESS OF CONVENTIONAL AND INNOVATIVE CHEMO-RADIATION IN LUNG CANCER.
    Bongers ML; de Ruysscher D; Oberije C; Lambin P; Uyl-de Groot CA; Belderbos J; Coupé VMH
    Int J Technol Assess Health Care; 2017 Jan; 33(6):681-690. PubMed ID: 29122046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Bittoni MA; Arunachalam A; Li H; Camacho R; He J; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e629-e645. PubMed ID: 29885945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure.
    Hessel FP
    Cost Eff Resour Alloc; 2006 Oct; 4():16. PubMed ID: 17022815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular cancer follow-up costs in Germany from 2000 to 2015.
    Michaeli T; Michaeli J; Michaeli D
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2249-2258. PubMed ID: 33885951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain).
    Corral J; Espinàs JA; Cots F; Pareja L; Solà J; Font R; Borràs JM
    BMC Health Serv Res; 2015 Feb; 15():70. PubMed ID: 25889153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients.
    John A; Baumgart A; Worst T; Heinzelbecker J
    Urol Int; 2018; 100(3):279-287. PubMed ID: 29514158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach.
    Tingstedt B; Andersson E; Flink A; Bolin K; Lindgren B; Andersson R
    World J Surg; 2011 Oct; 35(10):2298-305. PubMed ID: 21850604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
    Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.